VERAPAMIL HYDROCHLORIDE
NDC 71209-048, verapamil hydrochloride, tablet, extended release, from Cadila Pharmaceuticals Limited.
- Product NDC
- 71209-048
- Status
- Listed
- Labeler
- Cadila Pharmaceuticals Limited
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206173
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71209-048 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VERAPAMIL HYDROCHLORIDE240 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71209-048-05 | 71209004805 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-048-05) |
| 71209-048-10 | 71209004810 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-048-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5501208c-aa2b-47aa-89f7-87f4d4a73fd0
Use it
Look up 71209-048 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71209-048 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71209-048. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.